Amarenco P, Labreuche J. Lancet Neurol 2009;8:453-63
-
Upload
violet-pope -
Category
Documents
-
view
26 -
download
0
description
Transcript of Amarenco P, Labreuche J. Lancet Neurol 2009;8:453-63
Amarenco P, Labreuche J. Lancet Neurol 2009;8:453-63
Characteristics of selected major statin trials
Amarenco P, Labreuche J. Lancet Neurol 2009;8:453-63
Updated meta-analysis of major statin trials that assessed the effect of statins on fatal and non-fatal stroke
Amarenco P, Labreuche J. Lancet Neurol 2009;8:453-63
Updated meta-analysis of major statin trials that assessed the effect of statins on fatal stroke
Amarenco P, Labreuche J. Lancet Neurol 2009;8:453-63
Updated meta-analysis of major statin trials that assessed the effect of statins on haemorrhagic stroke
Amarenco P, Labreuche J. Lancet Neurol 2009;8:453-63
Association between reduction in LDL cholesterol concentration with stroke incidence among the major statins trials
Amarenco P, Labreuche J. Lancet Neurol 2009;8:453-63
Meta-analysis of statin trials that assessed the effect of intensive lipid-lowering therapy versus standard statin therapy on incidence
of fatal and non-fatal stroke and on major cardiovascular events
Amarenco P, Labreuche J. Lancet Neurol 2009;8:453-63